to Download the "Indo-US Business Magazine May-June 2011"

Corporate News
Indian-American Vijay Sazawal
Appointed to CINTAC
appointing Sazawal to CINTAC, said the Committee "will
advise me on trade issues facing the US civil nuclear
industry for use by me and other Department of
Commerce officials in our roles as members of the Civil
Nuclear Trade Working Group of the Trade Promotion
Coordinating Committee." It further said that "CINTAC
will provide consensus advice on the development and
administration of programmes and policies to expand US
civil nuclear exports and strengthen the competitiveness
of the industry."
Vijay Sazawal, an Indian-American nuclear industry
expert, has been appointed to the Civil Nuclear Trade
Advisory Committee (CINTAC) to advise the US
Commerce Department on trade issues related to the
industry. Sazawal, born in Srinagar, is 64 years old and
has more than 35 years of experience in the nuclear
industry covering the complete fuel cycle. He will serve on
the Committee for two years.
US Commerce Secretary Gary Locke, in a letter
Sazawal, currently Director of the government
programmes at USES Inc, a leading supplier of enriched
uranium fuel for commercial nuclear power plants
globally, graduated from the Tyndale Biscoe Memorial
High School and the Amar Singh College and has a
bachelor's degree in mechanical engineering from the
Banaras Hindu University and a master's in technology in
materials engineering from the College of Technology in
Bhopal.
He is a member of the Sigma Xi, the American Academy
of Mechanics, the American Society of Mechanical
Engineers and the American Nuclear Society.
Amrutanjan Health Care Ltd signed a memorandum of
understanding (MoU) with Austin Chemical of USA to
form a joint venture named Amrutanjan Pharmaessense
Ltd (Pharmaessense).
Amrutanjan Inks MoU
with US Firm to Form JV
leader in the US. Amrutanjan with its manufacturing
facility in Alathur, Chennai, said it would focus on supply
of non-GMP and cGMP intermediates and APIs from
pilot scale to commercial quantities.
Amrutanjan's fine chemicals division (now named Amrutanjan said the primary aim is to market
Pharmaessense) has already been providing value- pharmaceuticals manufactured at its facility that can
added services like contract research and manufacturing house 55 scientists and its new world class kilo lab/pilot
services (CRAMS) to several MNCs, the company said in plant that conforms to ICH Q7 guidelines (Class
a filing with the Bombay Stock Exchange (BSE).
100,000) in addition to fully equipped GLP analytical
lab. "With Austin's strength in sales and marketing,
Amrutanjan, an established manufacturer of OTC
distribution and sourcing and procurement, the
products for over a century, said it has been looking for
companies hope to evolve new synergies to create a
opportunities to enhance its chemicals division's market
dynamic, high-value platform.
penetration by strategic partnering with a marketing
INDO-US BUSINESS May-June 2011
40